Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Commonly available blood-pressure medication prevents epilepsy after severe brain injury

  • Critical new protein complex involved in learning, memory

  • Teachers' scare tactics may lead to lower exam scores

  • Financial incentives help economically-disadvantaged pregnant smokers quit, improve fetal growth

  • Regulating legal marijuana could be guided by lessons from alcohol, tobacco, study says

  • Want to quit smoking? New study says try 'self-expanding' activities

  • Mentor programs harm, more than help first-year teachers

  • Physicists push new Parkinson's treatment toward clinical trials

  • First brain images of African infants enable research into cognitive effects of nutrition

  • New way to enhance nerve growth following injury discovered

  •